Click the button below to contact us or submit your feedback about this product.
ImmunoArrayᵀᴹ Small Molecule Drug Microarray (CAT#: NA-0726-FY3)
Small Molecule Drug Microarray is a premier, high-throughput screening engine designed to accelerate drug discovery and mechanism-of-action (MoA) profiling. Deposited onto a standard 75mm x 25mm matrix utilizing advanced non-contact printing technology, the platform immobilizes an elite collection of 3375 small molecules-including over 1500 drugs, 800+ proven inhibitors, and 1000+ key chemical monomers. Backed by three technical replicates per spot to guarantee flawless data reproducibility, this versatile microarray serves as an indispensable tool for systematically identifying novel small-molecule ligands and modulators across a vast array of biological inputs, including target proteins, nucleic acids (RNA), cell lysates, and live cells.
| Specifications | |
|---|---|
| Size | 75 mm × 25 mm (Standard glass slide format) |
| Throughput Level | High-throughput ligand screening platform |
| Arraying Technology | Advanced non-contact printing technology (ensures optimal spot uniformity across the slide surface) |
| Quality Control | High statistical validation with 3 technical replicates per small molecule to maximize assay accuracy |
| Features | Diverse & Clinically Relevant Library: Features a robust collection of 3375 small molecule compounds, more than 800 highly targeted small molecule inhibitors, and over 1000 vital chemical monomers. Versatile Screening Compatibility: Engineered for absolute experimental flexibility, allowing high-throughput target discovery using purified proteins, complex cell lysates, antibodies, RNA molecules, or intact living cells. Precision Array Engineering: Manufactured with cutting-edge non-contact microarray printing technology to secure exceptional structural uniformity across the matrix, coupled with triplicate compound printing to eliminate false positives and increase data precision. |
| Application Fields | Enzyme Modulator Screening: Uncovering novel small molecule inhibitors, activators, or allosteric promoters for target proteases and enzymes. Receptor Ligand Discovery: High-throughput screening to identify specific small molecule ligands that bind to purified or recombinant receptor proteins. Phenotypic Live-Cell Screening: Mapping and capturing ligand-receptor interactions directly on the surface of intact, functional living cells. Specificity & Cross-Reactivity Evaluation: Conducting systematic profiling to evaluate the binding specificity, off-target liabilities, and cross-reactivity profiles of candidate small molecules. |
DatasheetFor Research Use Only | Not For Clinical Use
Related products
- ImmunoArrayᵀᴹ Paraneoplastic Neurological Syndrome (PNS) & Autoimmune Encephalitis (AE) Associated Autoantibody Detection Service/Antigen Microarray (CAT#: NA-0726-FY6)
- ImmunoArrayᵀᴹ Heparan Sulfate Glycan Microarray (CAT#: NA-0726-FY31)
- ImmunoArrayᵀᴹ Myasthenia Gravis-Related Autoantibody Detection Microarray Service (68-Antigen Array) (CAT#: NA-0726-FY14)
- ImmunoArrayᵀᴹ Glycosphingolipid (GSL) Glycan Microarray (CAT#: NA-0726-FY36)
- ImmunoArrayᵀᴹ MUC1 Glycopeptide Microarray (CAT#: NA-0726-FY38)
- ImmunoArrayᵀᴹ Cancer and Tumor-Related Autoantibody Detection Service (CAT#: NA-0726-FY16)
- ImmunoArrayᵀᴹ Systemic Autoimmune Disease-Related Autoantibody Detection Service (CAT#: NA-0726-FY27)
- ImmunoArrayᵀᴹ Extractable Nuclear Antigen (ENA) and Antinuclear Antibody (ANA) Detection Service (32 Antigens) (CAT#: NA-0726-FY25)
Services:
Resource:
Applications:
Online Inquiry